FDAAA Impact Analysis (Year 4): The REMS Retreat Continues - For Now
This article was originally published in RPM Report
Executive Summary
As the fifth year of the REMS era begins, FDA is imposing mandatory programs less frequently than it did even in the first year after the law creating formal risk management plans took effect. But there are some new trends to watch, including the evolution of REMS classes and the emergence of products with REMS-in-waiting.